The Hepagard Clinical Study

Many herbal supplements claim to help cleanse and detoxify the liver, and some have testimonials to support this. However, very few companies are willing to put their products to the test and clinically verify their claims. If they are not willing to scientifically test their product, how do you know if they are really telling the truth?

Here at Nutreance, we do things differently. When designing Hepagard, we decided that we only wanted to offer it to the public if it was clinically proven to reduce abdominal bloating, improve digestion, and increase energy levels for people struggling with a fatty liver.

Once the formula was finalized, we enlisted Princeton Consumer Research to conduct a placebo-controlled clinical study over the course of 30 days. 50 people who described themselves as at risk for developing fatty liver disease took part in the study. 30 participants were given Hepagard, while 20 other participants were given a placebo. Each was instructed to take the product daily and keep a daily journal of their experience.

The statistically significant results were as follows:

  • Within 2 weeks, 90% of participants reported reduced abdominal bloating, with more than 95% feeling less bloated by the end of the study.
  • After 2 weeks, 4 out of 5 reported less heartburn and indigestion, with more than 95% experiencing improved digestion by the end of the study.
  • Within 30 days, 4 out of 5 reported increased energy levels and less fatigue.
  • None of the participants reported any negative side effects.

For more details, click here to view the complete results of the study.